164 related articles for article (PubMed ID: 23329823)
1. Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia.
Lima M; Sato S; Enos RT; Baynes JW; Carson JA
J Appl Physiol (1985); 2013 Mar; 114(6):824-8. PubMed ID: 23329823
[TBL] [Abstract][Full Text] [Related]
2. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
3. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
5. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse.
Mehl KA; Davis JM; Berger FG; Carson JA
J Appl Physiol (1985); 2005 Dec; 99(6):2379-87. PubMed ID: 16288100
[TBL] [Abstract][Full Text] [Related]
6. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.
White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA
PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739
[TBL] [Abstract][Full Text] [Related]
7. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
Devine RD; Bicer S; Reiser PJ; Wold LE
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
[TBL] [Abstract][Full Text] [Related]
8. High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice.
Sato S; Gao S; Puppa MJ; Kostek MC; Wilson LB; Carson JA
Med Sci Sports Exerc; 2019 Sep; 51(9):1828-1837. PubMed ID: 30933004
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
[TBL] [Abstract][Full Text] [Related]
10. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and cachexia in ApcMin/+ mice.
Baltgalvis KA; Berger FG; Pena MM; Davis JM; Muga SJ; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R393-401. PubMed ID: 18056981
[TBL] [Abstract][Full Text] [Related]
12. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of skeletal muscle myosin isoforms in cancer cachexia.
Diffee GM; Kalfas K; Al-Majid S; McCarthy DO
Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1376-82. PubMed ID: 12372798
[TBL] [Abstract][Full Text] [Related]
15. Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism.
Welle S; Mehta S; Burgess K
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E993-E1001. PubMed ID: 21406613
[TBL] [Abstract][Full Text] [Related]
16. Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.
Samuels SE; Knowles AL; Tilignac T; Debiton E; Madelmont JC; Attaix D
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R133-9. PubMed ID: 11404286
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent regulation of postprandial muscle protein synthesis rates after milk protein ingestion in young men.
van Vliet S; Beals JW; Holwerda AM; Emmons RS; Goessens JP; Paluska SA; De Lisio M; van Loon LJC; Burd NA
J Appl Physiol (1985); 2019 Dec; 127(6):1792-1801. PubMed ID: 31725358
[TBL] [Abstract][Full Text] [Related]
18. Top-Down Proteomics Reveals Myofilament Proteoform Heterogeneity among Various Rat Skeletal Muscle Tissues.
Melby JA; Jin Y; Lin Z; Tucholski T; Wu Z; Gregorich ZR; Diffee GM; Ge Y
J Proteome Res; 2020 Jan; 19(1):446-454. PubMed ID: 31647247
[TBL] [Abstract][Full Text] [Related]
19. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia.
Smith KL; Tisdale MJ
Br J Cancer; 1993 Apr; 67(4):680-5. PubMed ID: 8471425
[TBL] [Abstract][Full Text] [Related]
20. Habitual Myofibrillar Protein Synthesis Is Normal in Patients with Upper GI Cancer Cachexia.
MacDonald AJ; Johns N; Stephens N; Greig C; Ross JA; Small AC; Husi H; Fearon KC; Preston T
Clin Cancer Res; 2015 Apr; 21(7):1734-40. PubMed ID: 25370466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
